Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.22 +0.73 (+2.76%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
39 40 Next >
Texas Pfizer Covid/Nursing 2022 Scholarship | Minority Student Grants Announced
Via Press Release Distribution Service
News headline image
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
From Pfizer Inc.
Via Business Wire
Online shop Etalaze announces shift to a new domain www.Etalaze.biz
Via AB Newswire
News headline image
North Carolina Physicians' Group Calls for Halt to Atrium COVID Vaccine Trial for Children
The North Carolina Physicians for Freedom (NCPFF), a large network of physicians and other health care professionals, called for the cessation of a clinical trial announced by the Atrium hospital... 
Via Newswire.com
Topics Death
News headline image
Awardees named for $20 million project to foster diversity in clinical trial research
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach... 
Via iCrowdNewswire
News headline image
Contraceptives Market New Innovations Trends, Research, Global Share and Growth Factor
Contraceptives Market New Innovations Trends, Research, Global Share and Growth Factor The use of advanced contraceptive methods and emergency contraceptives methods, especially for teenagers, and... 
Via iCrowdNewswire
Topics Economy
News headline image
Asia-Pacific Anti-Inflammatory Therapeutics Market Qualitative Insights on Application & Outlook by Share, Future Growth
Asia-Pacific Anti-Inflammatory Therapeutics Market Qualitative Insights on Application & Outlook by Share, Future Growth Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR... 
Via iCrowdNewswire
Topics Intellectual Property
News headline image
Pfizer to Acquire Biohaven Pharmaceuticals
From Pfizer Inc.
Via Business Wire
News headline image
Todos Medical Reports Day 14 Update from Ongoing 30-Day Case Study of Paxlovid Rebound Patient
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Setareh Williams Joins Cobbs Creek Healthcare as Managing Partner/Head of Real-World Evidence and Scientific Communications
Cobbs Creek Healthcare Expanding Into RWE/HEOR Area 
Via Newswire.com
News headline image
InnoLead Brings Global 1000 Innovation Leaders to Brooklyn
InnoLead is hosting its New York Impact conference in Brooklyn on May 18 and 19, 2022. The conference brings together leaders in large organizations who are responsible for innovation, strategy,... 
Via Newswire.com
News headline image
Pfizer Reports First-Quarter 2022 Results
From Pfizer Inc.
Via Business Wire
HER2-Targeted Therapies Introduced Early in Breast Cancer Treatment Offering Hope for Patients
Palm Beach, FL – May 4, 2022 – FinancialNewsMedia.com News Commentary – Globally, the R&D on breast cancer in all its forms has been steadily growing at a significant pace over the last several years... 
Via FinancialNewsMedia
News headline image
Pfizer Declares Second-Quarter 2022 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
From Pfizer Inc.
Via Business Wire
News headline image
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
From Pfizer Inc.
Via Business Wire
United Freedom Convoy launches NFT collection supporting those hard-hit by the pandemic; auctions off a special Maddie de Garay NFT
Via Get News
News headline image
Immunization Intelligence Leader STChealth Hosts Historical 1st Vaccine Intelligence Manufacturer Summit, Connecting Leading Vaccine Manufacturers Pfizer & GSK
About STChealth STChealth’s mission is to eradicate vaccine preventable disease and empower individuals through our innovative technology and service solutions. We deliver on our mission through... 
Via PRUnderground
Haier Biomedical Participates in the UN COVAX Program to Help Fight the Pandemic in Bangladesh
Via AB Newswire
News headline image
Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Names David M. Denton Chief Financial Officer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Alex Therapeutics to Provide Digital Solutions to German Patients
Berlin, Germany -- (SBWIRE) -- 03/30/2022 -- Digital therapies represent a huge growth area in German healthcare and have the potential to give many more patients access to a much broader selection of... 
Via SBWire
Topics Artificial Intelligence
News headline image
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential
From Pfizer Inc.
Via Business Wire
Acurx Pharmaceuticals Stands As Front-Line CDI Treatment Contender After Pfizer Misses Primary Endpoint In CDI Drug Trial (NASDAQ: ACXP)
Via AB Newswire
Race to Develop Universal ‘Variant-Proof’ Covid Vaccine Involves Several Players
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2022 – USA News Group – Whenever a new COVID-19 variant emergences, health authorities have had limited options to fight... 
Via FinancialNewsMedia
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.